eyenovia.com (EYEN) Year-over-year earnings per share growth for the last twelve months

Eyenovia Inc. - graphic logo of issuer EYEN

Eyenovia, Inc. (EYEN) operates within US jurisdiction, which eliminates external threats; however, global component supply chain disruptions could complicate production. The shift in quarterly EPS reflects the dynamics of these processes, where 91.10 represents the current metric. Meanwhile, the company is fighting for physician recognition of its ophthalmological innovations and for insurance reimbursement amid fierce competition.

Eyenovia Inc. (EYEN) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 07/03/2025

Analytical breakdowns for Eyenovia, Inc.

- share price and expert price forecast:
Summary company analysis:Eyenovia, Inc.
Flagship merchandise of eyenovia.com

To objectively assess the value of Eyenovia, Inc. (EYEN), the manager analyzes net earnings per share dynamics, which determine the speed of business scaling and the efficiency of capital allocation. Analyzing the current quarterly EPS rate allows for a comparison of earnings growth rates with market capitalization, which is critical for the biopharmaceutical sector, where the patent protection of the Optejet system must transform into a stable inflow of free cash flow.

Analysis of competing companies

Alcon Corp (ALC) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Bausch Health (BLCO)|Year-over-year earnings per share growth for the last twelve months glaukos.com|Apellis Pharmaceuticals (APLS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BLTE|OCUL - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth HROW (Harrow Inc)|Year-over-year net earnings per share change for the last twelve months Viridian Corp (VRDN)|LENZ - Year-over-year earnings per share growth for the last twelve months|Oculis - Year-over-year earnings per share growth rate for the last twelve months|EyePoint Pharmaceuticals (EYPT) - Year-over-year earnings per share growth for the last twelve months|Kodiak Sciences Inc (KOD) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ALDX|KALA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth IRD|OKYO: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adverum Biotechnologies ADVM|Quarterly EPS earnings growth Outlook Pharma OTLK|Clearside Biomedical - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months NBY|KPRX: Quarterly EPS earnings growth|ALIM - Year-over-year net earnings per share change for the last twelve months|GHSI (Guardion Health Sciences) - Quarterly EPS earnings growth|Ocuphire Pharma - Year-over-year net earnings per share trend for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OPT (Opthea)